Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia
- 1 June 2000
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 30 (6) , 526-535
- https://doi.org/10.1046/j.1365-2362.2000.00661.x
Abstract
The structure and function of neurons are changed not only during development of the central nervous system but also in certain neurological disorders, such as Alzheimer's disease and human immunodeficiency virus type 1 (HIV-1) -associated dementia. Immunological activation and altered production of neurotoxins and neurotrophins by brain macrophages are thought to play an important role in neuronal structure and function. This review describes the clinical and pathological features of both Alzheimer's disease and HIV-1-associated dementia and tries to interpret the role of the macrophage and astrocytes therein. The consequences of activation of macrophages by amyloid-β in Alzheimer's disease and HIV infection of macrophages in HIV-1-associated dementia and the similarities between these diseases will be discussed. Although the neuropathology of Alzheimer's disease and HIV-1-associated dementia differs, Alzheimer's disease is a cortical dementia and HIV-1-associated dementia is a subcortical dementia, the process of macrophage activation and the resulting pathways leading to neurotoxicity seem very similar. In both Alzheimer's disease and HIV-1-associated dementia, interaction of macrophages and astrocytes appear to play an important role.Keywords
This publication has 90 references indexed in Scilit:
- Immunohistochemical Evidence for a Macrophage Scavenger Receptor in Mato Cells and Reactive Microglia of Ischemia and Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1998
- Redox Regulation of Lipopolysaccharide(LPS)-Induced Interleukin-8 (IL-8) Gene Expression Mediated by NFκB and AP-1 in Human Astrocytoma U373 CellsBiochemical and Biophysical Research Communications, 1997
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Activation of Macrophages by Alzheimer β Amyloid PeptideBiochemical and Biophysical Research Communications, 1994
- Restricted expression of HIV1 in human astrocytes: molecular basis for viral persistence in the CNSResearch in Virology, 1994
- Nerve Growth Factor and Alzheimer's DiseaseReviews in the Neurosciences, 1994
- Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal culturesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990
- Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 familyNeuroscience Letters, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984